tiprankstipranks
China Literature Ltd. (HK:0772)
:0772

China Literature (0772) AI Stock Analysis

3 Followers

Top Page

HK:0772

China Literature

(0772)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
HK$38.00
▲(7.59% Upside)
Action:ReiteratedDate:01/13/26
The score is driven primarily by strong cash flow and a very solid balance sheet, which help offset the recent swing to a net loss. Technicals are constructive with price trending above key averages, but valuation is a major drag given the extremely high P/E and no dividend yield provided.
Positive Factors
Strong Cash Flow
The significant increase in free cash flow highlights strong cash generation, providing the company with operational flexibility and the ability to invest in growth opportunities.
Negative Factors
Profitability Challenges
The shift to a net loss indicates profitability challenges that could hinder reinvestment in the business and affect shareholder returns if not addressed.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Cash Flow
The significant increase in free cash flow highlights strong cash generation, providing the company with operational flexibility and the ability to invest in growth opportunities.
Read all positive factors

China Literature (0772) vs. iShares MSCI Hong Kong ETF (EWH)

China Literature Business Overview & Revenue Model

Company Description
China Literature Limited, an investment holding company, operates an online literature platform in the People's Republic of China. The company promotes intellectual properties primarily through its online literature platforms, such as QQ Reading a...
How the Company Makes Money
China Literature generates revenue through multiple streams, primarily by charging readers for premium content access on its platform. The company offers a subscription model, allowing users to pay for memberships that grant them access to exclusi...

China Literature Financial Statement Overview

Summary
Strong cash generation (free cash flow up 152.4% year over year) and a solid, low-leverage balance sheet (equity ratio 80.1%, debt-to-equity 0.009) support financial strength, but the swing from a HKD 804.9M profit (2023) to a HKD 209.2M loss (2024) is a material profitability setback despite 15.8% revenue growth.
Income Statement
58
Neutral
Balance Sheet
70
Positive
Cash Flow
82
Very Positive
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue7.12B8.12B7.01B7.63B8.67B8.53B
Gross Profit3.45B3.92B3.37B4.03B4.60B4.23B
EBITDA579.28M748.35M1.22B1.20B1.12B1.06B
Net Income136.24M-209.22M804.88M608.19M1.85B-4.50B
Balance Sheet
Total Assets23.20B22.95B23.19B22.73B23.30B21.32B
Cash, Cash Equivalents and Short-Term Investments7.05B7.62B6.28B7.51B7.21B6.26B
Total Debt206.47M166.21M238.10M617.98M1.45B1.33B
Total Liabilities4.04B4.57B4.16B4.78B6.11B6.22B
Stockholders Equity19.16B18.37B19.02B17.96B17.19B15.09B
Cash Flow
Free Cash Flow667.33M2.41B954.13M1.25B879.35M821.95M
Operating Cash Flow840.47M2.53B1.13B1.58B1.12B1.11B
Investing Cash Flow-1.26B-1.76B-3.39B528.10M936.23M-4.19B
Financing Cash Flow-471.75M-346.01M-510.82M-1.15B-349.99M-92.34M

China Literature Technical Analysis

Technical Analysis Sentiment
Negative
Last Price35.32
Price Trends
50DMA
32.75
Negative
100DMA
34.34
Negative
200DMA
35.18
Negative
Market Momentum
MACD
-2.03
Positive
RSI
33.39
Neutral
STOCH
21.85
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0772, the sentiment is Negative. The current price of 35.32 is above the 20-day moving average (MA) of 28.37, above the 50-day MA of 32.75, and above the 200-day MA of 35.18, indicating a bearish trend. The MACD of -2.03 indicates Positive momentum. The RSI at 33.39 is Neutral, neither overbought nor oversold. The STOCH value of 21.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0772.

China Literature Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
HK$26.86B-4.73-4.08%-10.26%-85.75%
65
Neutral
HK$4.49T22.3220.51%0.75%13.15%30.78%
60
Neutral
$48.67B4.58-11.27%4.14%2.83%-41.78%
60
Neutral
HK$16.73B5.3912.13%8.13%-1.40%22.37%
53
Neutral
HK$289.19B59.142.02%-2.92%-57.12%
50
Neutral
HK$1.85B-9.81-4.72%-23.80%
47
Neutral
HK$6.74B13.036.13%4.71%-7.61%-90.51%
* Communication Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0772
China Literature
26.30
-0.10
-0.38%
HK:0700
Tencent Holdings
496.60
-3.04
-0.61%
HK:9888
Baidu, Inc. Class A
109.60
19.60
21.78%
HK:9898
Weibo Corp Class A
68.50
0.50
0.74%
HK:1896
Maoyan Entertainment
5.80
-1.38
-19.22%
HK:2390
Zhihu, Inc. Class A
7.32
-4.02
-35.45%

China Literature Corporate Events

China Literature Grants 98,821 Restricted Share Units to Employees Under 2020 Scheme
Jan 13, 2026
China Literature Limited has granted a total of 98,821 restricted share units (RSUs) to employees under its 2020 RSU Scheme, with no consideration payable and a reference share price of HK$38.74 on the grant date. The bulk of the RSUs will vest in...
China Literature Sets March 2026 Board Meeting to Approve 2025 Results and Mull Dividend
Dec 29, 2025
China Literature Limited has scheduled a board meeting for March 17, 2026 to review and approve the annual results of the company and its subsidiaries for the financial year ending December 31, 2025, and to consider the publication of these result...
China Literature Renews Agreement with Tencent and Enters New Deals with YHKT
Dec 4, 2025
China Literature Limited has announced the renewal of its existing cooperation agreement with Tencent Computer, extending their collaboration on novel creation and competition organization through the 2026 Novel Creation and Solicitation Cooperati...
China Literature Announces Share Buy-back Plan to Boost Market Confidence
Dec 4, 2025
China Literature Limited has announced a voluntary on-market share buy-back plan, approved by its board of directors. The plan allows for the repurchase of up to 10% of the company’s issued shares, with a maximum fund allocation of HKD1.2 bi...
China Literature Updates Nomination Committee Guidelines
Dec 4, 2025
China Literature Limited has updated the terms of reference for its Nomination Committee, which is responsible for identifying and recommending director candidates, overseeing board performance evaluations, and developing nomination guidelines. Th...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 13, 2026